As part of this broader effort, CVS Health and Lilly are collaborating to help eligible Zepbound and Foundayo patients more easily access transparent pricing, inclusive of reimbursed and self-pay options, through the CVS Health app.
CVS Health offers a comprehensive approach to GLP-1 support at CVS Pharmacy locations and MinuteClinic, available virtually in nearly all states.
CVS Pharmacy offers a broad range of GLP-1 prescription medications, including both injectable and oral options from multiple manufacturers, along with new digital resources available on CVS.com.
Helping patients access lower-cost GLP-1 medications
Depending on how or whether a GLP-1 medication is covered, patients can face barriers such as prior authorization requirements, varying insurance coverage and confusion over the many ways to pay for prescriptions -- including insurance, cash-pay options, online portals, manufacturer coupons, vouchers and third-party discount cards.
CVS Pharmacy also participates in the Centers for Medicare & Medicaid Services Medicare GLP-1 Bridge program. The program runs through December 31, 2027, and eligible Medicare beneficiaries can access certain GLP-1 medications for $50 per month, offering more predictable and affordable pricing for patients who qualify.
Expanding access to clinical weight loss support
The program is available nationally in accordance with state-level regulations and is designed for self-paying adults ages 18 to 64 who are overweight or living with obesity and intend to pay out of pocket for clinical weight loss services. Patients seeking weight loss or metabolic health clinical support can visit MinuteClinic.com.
Putting pharmacists at the center of care
About CVS Health
Media contact
Amy Thibault 401-318-2865
[email protected]
SOURCE CVS Health
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
